Journal article
Early Life Factors Predict Abnormal Growth and Bone Accretion at Prepuberty in Former Premature Infants With/Without Neonatal Dexamethasone Exposure
Abstract
Growth, bone, and body composition were studied at prepuberty in former very low birth weight (VLBW) infants who received dexamethasone (DEX) for bronchopulmonary dysplasia (BPD) compared with VLBW infants without DEX and term-born infants (TERM) to identify early life risk factors for later low bone mass. Children (56 girls/63 boys, 5–10 y) previously studied in neonatal life were recruited into three groups: VLBW + DEX, VLBW – DEX, and TERM …
Authors
Wang D; Vandermeulen J; Atkinson SA
Journal
Pediatric Research, Vol. 61, No. 1, pp. 111–116
Publisher
Springer Nature
Publication Date
January 2007
DOI
10.1203/01.pdr.0000250206.79628.66
ISSN
0031-3998